Adaptive Biotechnologies
ADPT
27.93
-0.12
-0.43%
Adaptive Biotechnologies
US · ADPT
#2184 by market cap
Listed 2019
27.93
-0.12
-0.43%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About Adaptive Biotechnologies
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
- Founded
- 2009
- CEO
- Mr. Chad M. Robins
- Employees
- 624
- Headquarters
- Seattle, Washington, United States of America
- Fiscal year end
- 12-31
- Website
- adaptivebiotech.com
Company profile
- Exchange
- US
- Symbol
- ADPT
- Market-cap rank
- #2184
- Listing date
- 2019-06-27
- Market cap
- 4.52B
- Float cap
- 3.57B
- Shares out
- 161.88M
- Float shares
- 127.87M
Sectors & themes
Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.
Adaptive Biotechnologies discussion 0 comments